- Home
- DSL vs RLAY Comparison
DSL vs RLAY Comparison
Compare DSL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSL
- RLAY
- Stock Information
- Founded
- DSL 2013
- RLAY 2015
- Country
- DSL United States
- RLAY United States
- Employees
- DSL N/A
- RLAY N/A
- Industry
- DSL Trusts Except Educational Religious and Charitable
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSL Finance
- RLAY Health Care
- Exchange
- DSL Nasdaq
- RLAY Nasdaq
- Market Cap
- DSL 1.4B
- RLAY 1.1B
- IPO Year
- DSL N/A
- RLAY 2020
- Fundamental
- Price
- DSL $12.52
- RLAY $5.11
- Analyst Decision
- DSL
- RLAY Strong Buy
- Analyst Count
- DSL 0
- RLAY 9
- Target Price
- DSL N/A
- RLAY $20.88
- AVG Volume (30 Days)
- DSL 412.7K
- RLAY 1.3M
- Earning Date
- DSL 01-01-0001
- RLAY 11-06-2024
- Dividend Yield
- DSL 10.30%
- RLAY N/A
- EPS Growth
- DSL N/A
- RLAY N/A
- EPS
- DSL N/A
- RLAY N/A
- Revenue
- DSL N/A
- RLAY $10,006,000.00
- Revenue This Year
- DSL N/A
- RLAY N/A
- Revenue Next Year
- DSL N/A
- RLAY N/A
- P/E Ratio
- DSL N/A
- RLAY N/A
- Revenue Growth
- DSL N/A
- RLAY N/A
- 52 Week Low
- DSL $10.22
- RLAY $5.03
- 52 Week High
- DSL $12.96
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- DSL 40.76
- RLAY 28.59
- Support Level
- DSL $12.55
- RLAY $5.96
- Resistance Level
- DSL $12.77
- RLAY $6.39
- Average True Range (ATR)
- DSL 0.14
- RLAY 0.36
- MACD
- DSL 0.00
- RLAY -0.04
- Stochastic Oscillator
- DSL 34.13
- RLAY 5.10
About DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end fund. The fund's primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in securities, including money market funds, foreign corporate bonds, us corporate bonds, bank loans, collateralized loan obligations, and municipal bonds. The portfolio of the fund consists of various industries such as Healthcare, Technology, Construction, Automotive, Insurance, Beverage, Pharmaceuticals, Leisure, and others.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).